TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

VERELAN

VERAPAMIL HYDROCHLORIDE
Cardiovascular Approved 1990-05-29
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
35
Years on Market

Details

Status
Prescription
First Approved
1990-05-29
Routes
ORAL
Dosage Forms
CAPSULE, EXTENDED RELEASE

Companies

AZURITY
Active Ingredient: VERAPAMIL HYDROCHLORIDE

VERELAN Approval History

Loading approval history...

What VERELAN Treats

5 indications

VERELAN is approved for 5 conditions since its original approval in 1990. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Angina
  • Atrial Flutter
  • Atrial Fibrillation
  • Supraventricular Tachycardia
  • Hypertension
Source: FDA Label

VERELAN Competitors

Pro

3 other drugs also target L-type calcium channel. Compare mechanisms, indications, and trial activity.

VERELAN PM
AZURITY
CLEVIPREX
CHIESI
CARDAMYST
MILESTONE PHARMS USA
Drug = Competitor name Company = Manufacturer N indic. = FDA-approved indications → Date = Patent/exclusivity expiry

Competitors share the same molecular target (L-type calcium channel). Earlier expiry dates signal biosimilar/generic opportunities.

Drugs Similar to VERELAN

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

VERAPAMIL HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE
5 shared
MICRO LABS
Shared indications:
AnginaAtrial FlutterAtrial Fibrillation +2 more
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
ESMOLOL HYDROCHLORIDE
4 shared
Baxter
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter +1 more
BREVIBLOC IN PLASTIC CONTAINER
ESMOLOL HYDROCHLORIDE
4 shared
Baxter
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter +1 more
ESMOLOL HYDROCHLORIDE
ESMOLOL HYDROCHLORIDE
4 shared
AMNEAL
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter +1 more
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
ESMOLOL HYDROCHLORIDE
4 shared
HQ SPCLT PHARMA
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter +1 more
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
ESMOLOL HYDROCHLORIDE
4 shared
HQ SPCLT PHARMA
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter +1 more
BREVIBLOC
ESMOLOL HYDROCHLORIDE
3 shared
Baxter
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter
FLECAINIDE ACETATE
FLECAINIDE ACETATE
3 shared
REGCON HOLDINGS
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter
PROPAFENONE HYDROCHLORIDE
PROPAFENONE HYDROCHLORIDE
3 shared
GLENMARK PHARMS LTD
Shared indications:
Atrial FibrillationAtrial FlutterSupraventricular Tachycardia
RAPIBLYK
LANDIOLOL HYDROCHLORIDE
3 shared
AOP HLTH US
Shared indications:
Supraventricular TachycardiaAtrial FibrillationAtrial Flutter
AMLODIPINE BESYLATE AND VALSARTAN
AMLODIPINE BESYLATE
2 shared
ALEMBIC
Shared indications:
HypertensionAngina
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AMLODIPINE BESYLATE
2 shared
STRIDES PHARMA INTL
Shared indications:
HypertensionAngina
BETAPACE
SOTALOL HYDROCHLORIDE
2 shared
LEGACY PHARMA
Shared indications:
Atrial FibrillationAtrial Flutter
CADUET
AMLODIPINE BESYLATE
2 shared
PHARMACIA
Shared indications:
HypertensionAngina
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
NICARDIPINE HYDROCHLORIDE
2 shared
CHIESI
Shared indications:
AnginaHypertension
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
NICARDIPINE HYDROCHLORIDE
2 shared
CHIESI
Shared indications:
AnginaHypertension
CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
NICARDIPINE HYDROCHLORIDE
2 shared
CHIESI
Shared indications:
AnginaHypertension
CARDIZEM CD
DILTIAZEM HYDROCHLORIDE
2 shared
BAUSCH
Shared indications:
HypertensionAngina
CARDIZEM LA
DILTIAZEM HYDROCHLORIDE
2 shared
BAUSCH
Shared indications:
HypertensionAngina
CARTIA XT
DILTIAZEM HYDROCHLORIDE
2 shared
Teva
Shared indications:
HypertensionAngina
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

VERELAN FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory bypass tract ) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia Essential hypertension: Verapamil is indicated fo...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA019614 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.